{"product_id":"fgfr2-antibody-sc-f0779","title":"FGF Receptor 2 Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eFibroblast growth factors (FGFs) exert mitogenic and angiogenic effects on target cells by activating cell surface receptor tyrosine kinases. The FGF receptor family comprises four members: FGFR1 (flg), FGFR2 (bek, KGFR), FGFR3, and FGFR4. Each receptor possesses an extracellular ligand-binding domain, a transmembrane domain, and a cytoplasmic kinase domain. Depending on the literature source, FGFR2 may also be discussed as FGF Receptor 2 and Bek.\u003c\/p\u003e\u003cp\u003eReported cellular context includes cell membrane, cytoplasmic vesicle, golgi apparatus, and membrane, which can matter when signal is compared across treatments or changing cell states. Following FGFR2 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eFGFR2 is commonly interpreted in the context of immunology and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell membrane, cytoplasmic vesicle, and golgi apparatus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between cell membrane, cytoplasmic vesicle, and golgi apparatus across matched conditions\u003c\/li\u003e\n\u003cli\u003econtext differences tied to immune-cell state, activation, or lineage composition\u003c\/li\u003e\n\u003cli\u003esignal-dependent shifts after ligand, inhibitor, or growth-factor perturbation\u003c\/li\u003e\n\u003cli\u003eco-patterning with orthogonal markers and control conditions that clarify pathway state\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for FGFR2. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in FGFR2 reflect biology rather than handling. When interpreting FGFR2, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep FGFR2 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57577518825817,"sku":"F0779-20UL","price":169.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57577518858585,"sku":"F0779-100UL","price":399.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57577518891353,"sku":"F0779-2X100UL","price":599.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F0779-IHC1.jpg?v=1773598931","url":"https:\/\/absource.de\/products\/fgfr2-antibody-sc-f0779","provider":"Absource Diagnostics","version":"1.0","type":"link"}